drugset / Trial / NCT00174304

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

NCT00174304

Phase 4 Completed 1120 enrolled Viatris Inc.
RandomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

Timeline

Start
2004-10
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Subject Atorvastatin Small molecule 10 mg
Subject Atorvastatin Small molecule 80 mg